Organosamarium Benzene Chalcogenolate Complexes
series of studies by Brennan and co-workers, the 2(EPh)-/
PhEEPh redox couple has been shown to reduce elemental
chalcogen (E ) S) as exemplified in eq 5.4-16
sublimed before use. KSPh was prepared by the addition of 1 equiv
of PhSSPh to 2 equiv of K sand. Stirring overnight yielded a white
toluene insoluble material. Complete elemental analyses were
performed by Analytische Laboratorien (Lindlar, Germany). Com-
plexometric metal analyses were carried out in house as previously
described.27
8Ln(SPh)3 + 3/4S8 THF8 Ln8S6(SPh)12(THF)8 + 6PhSSPh
(5)
(C5Me5)2Sm(SPh)(THF), 1. In a nitrogen filled glovebox,
PhSSPh (19 mg, 0.088 mmol) in 5 mL of THF was added to a
stirring solution of purple (C5Me5)2Sm(THF)2 (100 mg, 0.177
mmol) in 5 mL of THF. A clear orange solution immediately
formed. After the mixture was stirred overnight, the orange solution
was evaporated to dryness to yield 1 as an orange powder (95 mg,
90%). Crystals of 1 suitable for X-ray diffraction were grown at
-35 °C from a concentrated toluene solution. 1H NMR (500 MHz,
To determine if the ligand-based reductive chemistry
observed for (C5Me5)3Sm could be mimicked using the
Brennan reductants, (EPh)-, the synthesis of complexes such
as (C5Me5)2Sm(EPh)(THF) and [(C5Me5)2Sm(EPh)]2 was of
interest. These complexes could be more synthetically
accessible than the highly reactive (C5Me5)3Sm (which, for
example, ring opens THF1) and would provide a new option
for reductive lanthanide chemistry with triValent lanthanide
metallocene complexes. The desired series of complexes
seemed accessible on the basis of the existence of related
compounds in the literature such as (C5Me5)2Yb(SPh)(NH3),18
(C5Me5)2Yb(TePh)(NH3),19 (C5Me5)2Sm(THF)(TeC6H2Me3-
2,4,6),20 (C5Me5)2Sm(THF)(SeC6H2(CF3)3-2,4,6),21 and [(C5H4-
CMe3)2Y(µ-SePh)]2.22 Accordingly, we prepared the orga-
nosamarium complexes (C5Me5)2Sm(EPh)(THF) and [(C5-
Me5)2Sm(EPh)]2 (E ) S, Se, Te) and report here on their
synthesis, structure, and reactivity.
THF-d8): 1.19 (s, 30H, C5Me5, ∆ν1/2 ) 2 Hz), 6.86 (t, 1H, 3JHH
)
7 Hz, p-H), 5.87 (d, 2H, 3JHH ) 8 Hz, o-H), 6.59 (t, 2H, 3JHH ) 8
Hz, m-H). 13C NMR (500 MHz, THF-d8, 25 °C): δ 17.8 (C5Me5),
116.8 (C5Me5), 129.8 (o-phenyl), 128.4 (m-phenyl), 121.0 (p-
phenyl). IR: 3057 w, 2961 m, 2907 s, 2856 s, 2725 w, 1660 w,
1579 m, 1532 w, 1475 s, 1436 s, 1378 s, 1262 m, 1162 m, 1085 s,
1046 s, 1023 s, 992 s, 895 m, 822 s, 802 s, 737 s, 694 s, 568 w
cm-1. Anal. Calcd for C30H43OSSm: Sm, 25.0. Found: Sm, 24.9.
Sublimation of 1 at 155 C at 8 × 10-4 Torr afforded 4 in 8% yield
(see below).
(C5Me5)2Sm(SePh)(THF), 2. As described for 1, 2 was obtained
as an orange powder (113 mg, 98%) from PhSeSePh (27 mg, 0.088
mmol) and (C5Me5)2Sm(THF)2 (100 mg, 0.177 mmol). Crystals of
2 suitable for X-ray diffraction were grown at -35 °C from a
concentrated toluene solution. 1H NMR (500 MHz, THF-d8): 1.18
Experimental Section
The manipulations described below were performed under argon
or nitrogen with rigorous exclusion of air and water using Schlenk,
vacuum line, and glovebox techniques. Solvents were saturated with
UHP grade argon (Airgas) and dried by passage through Glass-
contour drying columns before use. NMR solvents were dried over
NaK and vacuum transferred before use. NMR spectra were
3
(s, 30H, C5Me5, ∆ν1/2 ) 2 Hz), 7.01 (t, 1H, JHH ) 8 Hz, p-H),
3
3
6.58 (d, 2H, JHH ) 8 Hz, o-H), 6.71 (t, 2H, JHH ) 7 Hz, m-H).
13C NMR (500 MHz, THF-d8): δ 17.8 (C5Me5), 116.7 (C5Me5),
133.2 (o-phenyl), 128.6 (m-phenyl), 122.4 (p-phenyl). IR: 3061
w, 2964 m, 2907 s, 2856 s, 2725 w, 1575 s, 1471 s, 1436 s, 1378
m, 1262 m, 1162 m, 1096 s, 1069 s, 1046 s, 1019 s, 818 s, 799 s,
733 s, 694 s, 633 s, 579 w, 555 w, 521 w cm-1. Anal. Calcd for
C30H43OSeSm: Sm, 23.2. Found: Sm, 23.8.
1
recorded with a Bruker DRX 400 or 500 MHz systems. The H
and 13C NMR spectra of the initially isolated powders match the
NMR spectra of the isolated crystals for 1-6. Infrared spectra were
recorded as thin films obtained from THF-d8 (1-3) or C6D6 (4-6)
on the silicon window of the probe of an ASI ReactIR 1000
instrument.23 (C5Me5)2Sm(THF)2,24 (C5Me5)2Sm,25 and [(C5Me5)2-
Sm][(µ-Ph)2BPh2]26 were prepared as previously described. PhSSPh,
PhSeSePh, and PhTeTePh were purchased from Aldrich and
(C5Me5)2Sm(TePh)(THF), 3. As described for 1, 3 was obtained
as an orange powder (62 mg, 95%) from PhTeTePh (38 mg, 0.094
mmol) and (C5Me5)2Sm(THF)2 (107 mg, 0.19 mmol). Crystals of
3 suitable for X-ray diffraction were grown at 25 °C from a
concentrated toluene solution. 1H NMR (500 MHz, THF-d8): 1.23
3
(s, 30H, C5Me5, ∆ν1/2 ) 2 Hz), 7.10 (t, 1H, JHH ) 7 Hz, p-H),
3
3
(13) Freedman, D.; Emge, T. J.; Brennan, J. G. Inorg. Chem. 2002, 41,
492.
(14) Fitzgerald, M.; Emge, T. J.; Brennan, J. G. Inorg. Chem. 2002, 41,
3528.
(15) Kornienko, A. Y.; Huebner, L.; Freedman, D.; Emge, T. J.; Brennan,
J. G. Inorg. Chem. 2003, 42, 8476.
(16) Kornienko, A. Y.; Emge, T. J.; Kumar, G. A.; Riman, R. E.; Brennan,
J. G. J. Am. Chem. Soc. 2005, 127, 3501.
(17) Evans, W. J. Coord. Chem. ReV. 2000, 206-207, 263.
(18) Zalkin, A.; Henly, T. J.; Andersen, R. A. Acta Crystallogr. 1987, C43,
233.
(19) Berg, D. J.; Andersen, R. A.; Zalkin, A. Organometallics 1988, 7,
1858.
(20) Recknagel, A.; Noltemeyer, M.; Stalke, D.; Pieper, U.; Schmidt, H.;
Edelman, F. T. J. Organomet. Chem. 1991, 411, 347.
(21) Poremba, P.; Noltemeyer, M.; Schmidt, H.; Edelman, F. T. J.
Organomet. Chem. 1995, 501, 315.
(22) Beletskaya, I. P.; Voskoboynikov, A. Z.; Shestakova, A. K.; Yanovsky,
A. I.; Fukin, G. K.; Zacharov, L. N.; Struchkov, Y. T.; Schumann, H.
J. Organomet. Chem. 1994, 468, 121.
7.01 (d, 2H, JHH ) 7 Hz, o-H), 6.69 (t, 2H, JHH ) 7 Hz, m-H).
13C NMR (500 MHz, THF-d8): δ 18.3 (C5Me5), 116.9 (C5Me5),
139.6 (o-phenyl), 128.8 (m-phenyl), 124.0 (p-phenyl). IR: 3053
w, 2957 s, 2922 s, 2856 s, 2725 w, 1942 w, 1876 w, 1799 w, 1741
w, 1660 w, 1571 m, 1471 m, 1436 s, 1378 m, 1262 s, 1096 s,
1061 s, 1015 s, 864 m, 802 s, 725 s, 687 s cm-1. Anal. Calcd for
C30H43OSmTe‚1/2THF: C, 52.38; H, 6.46; Sm, 20.49; Te, 17.39.
Found: C, 52.81; H, 6.26; Sm, 20.60; Te, 17.75.
[(C5Me5)2Sm(µ-SPh)]2, 4. In an argon-filled glovebox free of
coordinating solvents, PhSSPh (55 mg, 0.25 mmol) in toluene (2
mL) was added slowly to a stirring green solution of (C5Me5)2Sm
(211 mg, 0.50 mmol) in toluene (5 mL). The solution immediately
turned dark red. After the reaction mixture was stirred overnight,
the solvent was removed by rotary evaporation to yield 4 as a red
orange crystalline powder (258 mg, 97%). Crystals of 4 suitable
for X-ray diffraction were grown at -35 °C from a concentrated
(23) Evans, W. J.; Johnston, M. A.; Ziller, J. W. Inorg. Chem. 2000, 39,
3421.
(24) Evans, W. J.; Bloom, I.; Hunter, W. E.; Atwood, J. L. Organometallics
1985, 4, 112.
(25) Evans, W. J.; Hughes, L. A.; Hanusa, T. P. Organometallics 1986, 5,
1285.
(26) Evans, W. J.; Seibel, C. A.; Ziller, J. W. J. Am. Chem. Soc. 1998,
120, 6745.
(27) Evans. W. J.; Engerer, S. C.; Coleson, K. M. J. Am Chem. Soc. 1981,
103, 6672.
Inorganic Chemistry, Vol. 44, No. 12, 2005 4327